InspireMD Inc (NSPR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:InspireMD Inc (NSPR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011148
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InspireMD Inc (InspireMD), formerly Saguaro Resources Inc is a medical device company that develops and commercializes stent platform MGuard technology. The company’s products include carotid embolic prevention system, Mguard embolic prevention system and Mguard prime. Its MGuard is based on net that is wrapped with an expandable MicroNet. InspireMD uses MGuard technology, which develops products that are applied in interventional cardiology and other vascular procedures. The company’s MGuard prime include mesh sleeve wrapped around a cobalt-chromium stent. It utilizes its technology to make products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company markets its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Tel Aviv, Israel.

InspireMD Inc (NSPR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
InspireMD Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
InspireMD Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
InspireMD Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
InspireMD Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
InspireMD Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
InspireMD Inc, Medical Equipment, Deal Details 11
Venture Financing 11
InspireMD Raises USD0.2 Million in Venture Financing 11
InspireMD Raises USD0.6 Million in Venture Financing 12
Partnerships 13
InspireMD Amends Licensing Agreement With Svelte Medical For MGuard Prime 13
InspireMD Partners with Penumbra 14
Equity Offering 15
InspireMD to Raise USD0.8 Million in Private Placement of Series D Preferred Shares 15
InspireMD Prices Public Offering of Shares and Warrants for USD7.5 Million 16
InspireMD Raises USD14.6 Million in Public Offering of Preferred Stock and Warrants 17
InspireMD Raises USD1.1 Million in Public Offering of Shares and Warrants 18
InspireMD Raises USD0.6 Million in Private Placement of Shares and Warrants 19
InspireMD Raises USD14 Million in Public Offering of Shares and Warrants 21
InspireMD Raises USD8 Million in Private Placement of Shares and Warrants 22
InspireMD Files Registration Statement For Public Offering Of Shares For Up To US$40 Million 24
InspireMD Announces Rights Offering Of Shares 25
InspireMD Completes Public Offering Of Shares For US$25 Million 26
InspireMD Completes Private Placement Of US$9 Million 28
Debt Offering 29
InspireMD Completes Private Placement Of Convertible Debentures Due 2014 For US$11 Million 29
InspireMD Inc – Key Competitors 30
InspireMD Inc – Key Employees 31
InspireMD Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Aug 08, 2017: Inspire Reports Double Digit Sequential and Year-Over-Year Revenue Growth for the Second Quarter of 2017 33
Aug 08, 2017: InspireMD Reports Double Digit Sequential and Year-Over-Year Revenue Growth for the Second Quarter of 2017 35
Feb 16, 2017: InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 37
Nov 14, 2016: InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2016 39
Aug 09, 2016: InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016 41
May 10, 2016: InspireMD Reports Financial Results for the First Quarter Ended March 31, 2016 43
Mar 28, 2016: InspireMD Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015 45
Corporate Communications 47
Jun 02, 2017: InspireMD Announces Appointment of Paul Stuka as Chairman of the Board 47
Oct 26, 2016: InspireMD Announces Appointment of Medical Device Industry Veteran Agustin Gago as Chief Commercial Officer 48
Sep 07, 2016: InspireMD Appoints Thomas Kester to Board of Directors 49
Jan 22, 2016: InspireMD Aligns Operations and Leadership Team, Appoints Isaac Blech as Vice Chairman of the Board 50
Legal and Regulatory 51
Aug 22, 2017: InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency and Expectation to Regain Compliance 51
Jul 21, 2016: InspireMD Regains Compliance With NYSE MKT Listing Standards 52
Product News 53
Nov 28, 2016: InspireMD to Present at LD Micro Main Event on December 6 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
InspireMD Inc, Medical Equipment, Key Facts, 2016 2
InspireMD Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
InspireMD Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
InspireMD Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
InspireMD Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
InspireMD Inc, Deals By Market, 2011 to YTD 2017 9
InspireMD Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
InspireMD Raises USD0.2 Million in Venture Financing 11
InspireMD Raises USD0.6 Million in Venture Financing 12
InspireMD Amends Licensing Agreement With Svelte Medical For MGuard Prime 13
InspireMD Partners with Penumbra 14
InspireMD to Raise USD0.8 Million in Private Placement of Series D Preferred Shares 15
InspireMD Prices Public Offering of Shares and Warrants for USD7.5 Million 16
InspireMD Raises USD14.6 Million in Public Offering of Preferred Stock and Warrants 17
InspireMD Raises USD1.1 Million in Public Offering of Shares and Warrants 18
InspireMD Raises USD0.6 Million in Private Placement of Shares and Warrants 19
InspireMD Raises USD14 Million in Public Offering of Shares and Warrants 21
InspireMD Raises USD8 Million in Private Placement of Shares and Warrants 22
InspireMD Files Registration Statement For Public Offering Of Shares For Up To US$40 Million 24
InspireMD Announces Rights Offering Of Shares 25
InspireMD Completes Public Offering Of Shares For US$25 Million 26
InspireMD Completes Private Placement Of US$9 Million 28
InspireMD Completes Private Placement Of Convertible Debentures Due 2014 For US$11 Million 29
InspireMD Inc, Key Competitors 30
InspireMD Inc, Key Employees 31
InspireMD Inc, Other Locations 32
InspireMD Inc, Subsidiaries 32

★海外企業調査レポート[InspireMD Inc (NSPR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NovoCure Ltd (NVCR)-医療機器分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • Wistron Corporation:企業の戦略・SWOT・財務分析
    Wistron Corporation - Strategy, SWOT and Corporate Finance Report Summary Wistron Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Rockwell Medical Inc (RMTI)-医療機器分野:企業M&A・提携分析
    Summary Rockwell Medical Inc (Rockwell) is a bio pharmaceutical company focusing on the development, manufacture and distribution of products and services for the treatment of iron deficiency, secondary hyperparathyroidism; end-stage renal disease (ESRD) and chronic kidney disease. Its major product …
  • Cellular Biomedicine Group Inc (CBMG):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellular Biomedicine Group Inc (CBMG) is a clinical stage biopharmaceutical firm that develops biomedicine, immunotherapy products for cancer and stem cell therapies to address patient specific medical conditions. The firm’s products comprise clinical treatment protocols for the treatment of …
  • Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析
    Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Mazda Motor Corporation:企業の戦略・SWOT・財務分析
    Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report Summary Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • DCS Corporation:企業の戦略・SWOT・財務情報
    DCS Corporation - Strategy, SWOT and Corporate Finance Report Summary DCS Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Noven Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Henry M Jackson Foundation for the Advancement of Military Medicine Inc-製薬・医療分野:企業M&A・提携分析
    Summary The Henry M Jackson Foundation for the Advancement of Military Medicine Inc (HJF) is a private not-for-profit organization that offers military medical research and educational services. The organization’s services include proposal development, research administration, program management, te …
  • Tecpetrol SA:企業の戦略的SWOT分析
    Tecpetrol SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • New York Power Authority:企業の戦略・SWOT・財務分析
    New York Power Authority - Strategy, SWOT and Corporate Finance Report Summary New York Power Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • GAIL (India) Limited:企業の戦略・SWOT・財務情報
    GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report Summary GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Corning Inc (GLW):企業の財務・戦略的SWOT分析
    Corning Inc (GLW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AEP Texas Inc:企業の戦略的SWOT分析
    AEP Texas Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Konecranes Plc:企業のM&A・事業提携・投資動向
    Konecranes Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Konecranes Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Japan Petroleum Exploration Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Japan Petroleum Exploration Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Japan Petroleum Exploration Co Ltd (JAPEX) is an oil and gas company that offers exploration, development, production, and sales of oil, natural gas, and other energy resources. The co …
  • Moberg Pharma AB (MOB):製薬・医療:M&Aディール及び事業提携情報
    Summary Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma treats fungal infection or psoriasis, discolored and fungus-damaged …
  • Lanco Infratech Ltd:発電所・企業SWOT分析
    Lanco Infratech Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Neuren Pharmaceuticals Ltd (NEU):企業の財務・戦略的SWOT分析
    Summary Neuren Pharmaceuticals Ltd (Neuren Pharma) is a biopharmaceutical company that develops drugs for brain injury, neurodevelopmental and neurodegenerative disorders. The company provides pipeline products such as trofinetide and NNZ-2591. Its trofinetide has a pharmacokinetic profile, which is …
  • Intracom Holdings SA (INTRK):企業の財務・戦略的SWOT分析
    Intracom Holdings SA (INTRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆